The autoimmune disease diagnosis market, valued at USD 5.72 billion in 2024, is projected to reach USD 10.70 billion by 2032, growing at a CAGR of 8.15%. This strong upward trend reflects a global rise in autoimmune disorders and a growing demand for accurate, early diagnostic solutions.   Key Market Drivers 1. Rising Prevalence of Autoimmune Diseases Conditions...